Unlocking the Power of Pharmacovigilance: An Adaptive Approach to an Evolving Drug Safety Environment - Jan '07
Co-developed by the Pharmaceutical Industry Group and the firm's Health Research Institute, this report is a focused analysis of the current state of drug safety monitoring (known as pharmacovigilance) and a guide to field-tested operational strategies that can be employed to improve current pharmacovigilance practices.
Overview:
This new report provides a focused analysis of the current state of drug safety monitoring (known as pharmacovigilance) and a guide to field-tested operational strategies that can be employed to improve current pharmacovigilance practices. The report was co-developed by the Pharmaceutical Industry Group and the firm's Health Research Institute.
To help our clients better understand and address the emerging trends in pharmacovigilance, we analyzed post-market drug safety activities. Based on PricewaterhouseCoopers research, including interviews with industry experts on patient safety and pharmacovigilance and consultations with thought leaders who have successfully addressed similar challenges in other disciplines, the report identifies suggestions to:
develop clearly-defined safety roles and responsibilities,
implement enhanced communications with patients and physicians,
standardize pharmacovigilance processes and data management, and
adopt risk management strategies employed elsewhere by leading corporate compliance operations.
To assist you in using this publication (both with your teams and with your clients), the sections below provide access to marketing collateral and additional information about the report.
Overview:
This new report provides a focused analysis of the current state of drug safety monitoring (known as pharmacovigilance) and a guide to field-tested operational strategies that can be employed to improve current pharmacovigilance practices. The report was co-developed by the Pharmaceutical Industry Group and the firm's Health Research Institute.
To help our clients better understand and address the emerging trends in pharmacovigilance, we analyzed post-market drug safety activities. Based on PricewaterhouseCoopers research, including interviews with industry experts on patient safety and pharmacovigilance and consultations with thought leaders who have successfully addressed similar challenges in other disciplines, the report identifies suggestions to:
develop clearly-defined safety roles and responsibilities,
implement enhanced communications with patients and physicians,
standardize pharmacovigilance processes and data management, and
adopt risk management strategies employed elsewhere by leading corporate compliance operations.
To assist you in using this publication (both with your teams and with your clients), the sections below provide access to marketing collateral and additional information about the report.
